RxDoctor Payments Data

Ashish Chavda

Interventional Pain Medicine · Louisville, CONPI 1447549563

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,356 of the $1,539 with a category attached, or 88.1%. 12 manufacturers reported payments, led by Boston Scientific at 39.0% of the total. That places this record below the midpoint for interventional pain medicine clinicians in CO, where the typical reported total is $1,539.

$1,539in general payments, 2019–2025

Across 50 payments — averaging $30.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$600
  • AbbVie$290
  • Biogen$208
  • SPR Therapeutics, Inc$94
  • Medtronic$91
  • Abbott$90
  • plus $166 from 6 others

What the payments were for

  • Food & beverage$1,35688%
  • Education$18312%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,539 in reported general payments places this provider in the 50th percentile of 25 interventional pain medicine providers in Colorado.

See all interventional pain medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$157,955
Medicare patients
404
Services billed
1,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine21$5,635
Gabapentin193$4,632
Pregabalin119$3,841
Acetaminophen15$2,911
Lidocaine16$1,672
Celecoxib47$1,350
Duloxetine Hcl57$847
Nortriptyline Hcl40$659
Tizanidine Hcl22$600
Topiramate32$568
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$506
Oxycodone Hcl41$499
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$463
Amitriptyline Hcl14$348
Cyclobenzaprine Hcl26$314

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Louisville

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →